SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-17-001373
Filing Date
2017-01-09
Accepted
2017-01-09 16:14:20
Documents
1
Period of Report
2017-01-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v456621_form3a.html 3/A  
1 OWNERSHIP DOCUMENT v456621_form3a.xml 3/A 2760
  Complete submission text file 0001144204-17-001373.txt   4160
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address RESTON, HUNTINGTON RD CAMBRIDGE X0 CB3 0LH
Business Address
Kumar Rajinder (Reporting) CIK: 0001693951 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-13341 | Film No.: 17517668